Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institut du Cancer de Montpellier - Val d'Aurelle
With
Pfizer
Sanofi
Chugai Pharmaceutical
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically proven adenocarcinoma of the colon or rectum without previous resection, or clinically asymptomatic (with or without stent)
Hepatic unresectable metastases R0: due to close vascular contact, or due to liver remaining mass less than 25 to 30 % of functional liver.
Not optimally resectable metastases
Extra-hepatic disease will be accepted in case of: asymptomatic primary tumour or tumor requiring no urgent surgery (in less than 3 months); three of less than three lung metastases (thoracic scan diameter less than 2 cm) and potentially respectable.
Synchronous and metachronous hepatic metastases
WHO performance status 0-1
Adjuvant chemotherapy allowed, except oxaliplatin and irinotecan based combination.
No prior treatment of the liver metastases, whatever.
Life expectancy equal or more than 3 months
You may not be if
\-
Clareo Health | Intensified Chemotherapy in CRC After Resection of Liver Metastases
